CSIMarket
 
Psychemedics Corp  (PMD)
Other Ticker:  
 
    Sector  Healthcare    Industry Medical Laboratories
   Industry Medical Laboratories
   Sector  Healthcare
 

Psychemedics Growth Comparisons

Select each growth Category to receive further Information



PMD Revenue Growth Rate Comparisons Company Industry Sector S&P 500
Y / Y Revenue Growth (Q3 MRQ) -21.87 % - - -0.55 %
Q / Q Revenue Growth (Q3 MRQ) 0.63 % - - -1.18 %
Y / Y Revenue Growth (for 12 months ending Q3 TTM) -16.41 % - - %
Seq. Revenue Growth (for 12 months ending Q3 TTM) -6.16 % - - 0.08 %
Revenue 5 Year Average Growth -8.66 % 20.03 % 10.74 % 11.13 %


PMD's Growth Comparisons in III. Quarter 2023




Psychemedics reported -21.87% year on year Revenue decline in the third quarter 2023, and Medical Laboratories industry with %, and less than % no change in the Healthcare sector. Slow third quarter sales in the Medical Laboratories industry and Healthcare sector, were portrayed in Psychemedics's results, which underperformed overall market.

Comparing the company's Revenue to the second quarter results, sales were higher by 0.63% . On the yearly basis, average annual sales growth for Psychemedics is -8.66%, while S & P 500's including only Businesses with the third quarter 2023 earnings, average annual sales growth is 11.13% over the past five years.


Growth Rates of PMD's Income in the third quarter 2023


PMD Operating Income Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Operating Income Change (Q3 MRQ) - - -41.68 % 0.59 %
Seq. Operating Income Change (Q3 MRQ) - - 37.14 % 7.23 %
Y / Y Operating Income Growth (Q3 TTM) - -48.95 % -26.59 % -9.01 %
Seq. Operating Income Growth (Q3 TTM) - -19.85 % -12.38 % -0.23 %
Operating Income 5 Year Avg. Change - - 10.15 % 10.86 %


Income from Cont. Ops. Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Income from Cont. Ops. Change (Q3 MRQ) - - -77.97 % 1.83 %
Seq. Income from Cont. Ops. Change (Q3 MRQ) - - 384.2 % 10.6 %
Y / Y Income from Cont. Ops. Change (Q3 TTM) - -88.69 % -56.82 % -8.43 %
Seq. Income from Cont. Ops. Change (Q3 TTM) - -79.75 % -32.2 % 0.4 %
Income from Cont. Ops. 5 Year Avg. Change - - 23.15 % 2.84 %

PMD Net Income Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Net Income Growth (Q3 MRQ) - - 7.04 % 7.49 %
Q / Q Net Income Growth (Q3 MRQ) - - 2333.8 % 14.75 %
Y / Y Net Income Change (Q3 TTM) - -85.7 % -32.49 % -6.17 %
Seq. Net Income Change (Q3 TTM) - -75.61 % 3.48 % 1.93 %
Net Income 5 Year Avg. Growth - - 23.18 % 3.12 %

PMD's EPS Growth Rates


EPS from Cont. Ops. Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y EPS from Cont. Ops. Change (Q3 MRQ) - - -77.97 % 1.83 %
Seq. EPS from Cont. Ops. Change (Q3 MRQ) - - 384.2 % 10.6 %
Y / Y EPS from Cont. Ops. Change (Q3 TTM) - - - -
Seq. EPS from Cont. Ops. Change (Q3 TTM) - - - 117.26 %
EPS from Cont. Ops. 5 Year Avg. Growth - - 23.15 % 2.84 %



PMD EPS Net Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y EPS Net Growth (Q3 MRQ) - - 7.04 % 2.84 %
Q / Q EPS Net Growth (Q3 MRQ) - - 2333.8 % 14.75 %
Y / Y EPS Net Change (for 12 months ending Q3 TTM) - - - 60498.58 %
Seq. EPS Net Change (for 12 months ending Q3 TTM) - 1.35 % - 115.79 %
EPS Net 5 Year Avg. Change - - 23.18 % 3.12 %



Psychemedics reported bottom-line of $ -0.36 in the third quarter, compare to $ -0.02 in the same quarter a year ago. Medical Laboratories industry fell by %, while Healthcare sector increased by 7.04%, and overall market improved by 7.49%.

Comparing company's EPS to the second quarter results, income per share were higher by 0.63% . On the yearly basis, average annual income per share growth for Psychemedics is -8.66%, while S & P 500's including only the businesses with the third quarter 2023 Results, average annual income per share growth is 3.12% over the past five years.

PMD Cash Flow Growth Rates


Free Cash Flow Growth Rates Company Industry Sector S&P 500
Y / Y Free Cash Flow Change (Q3 MRQ) - -19.82 % 4.9 % 25.82 %
Seq. Free Cash Flow Change (Q3 MRQ) - -13.85 % 51.72 % 28.6 %
Y / Y Free Cash Flow Change (Q3 TTM) - -12.98 % -8.46 % -3.04 %
Seq. Free Cash Flow Change (Q3 TTM) - 18.51 % 2.41 % 11.75 %
Free Cash Flow 5 Year Avg. Change -9.85 % 23.84 % 18.45 % 23.3 %

Net Cash Flow Growth Rates Company Industry Sector S&P 500
Y / Y Net Cash Flow Change (Q3 MRQ) - - 8.44 % -
Seq. Net Cash Flow Change (Q3 MRQ) - -71.18 % - -
Y / Y Net Cash Flow Change (Q3 TTM) - - - -
Seq. Net Cash Flow Change (Q3 TTM) - - 17.06 % -
Net Cash Flow 5 Year Avg. Change -8.19 % 49.04 % 0.72 % 48.8 %

Capital Expenditures Company Industry Sector S&P 500
Y / Y Capital Expenditures Change (Q3 MRQ) -61.54 % -16.38 % 3.34 % 69 %
Seq. Capital Expenditures Change (Q3 MRQ) -37.5 % -2.11 % 5.51 % 16.39 %
Y / Y Capital Expenditures Change (Q3 TTM) -19.17 % -5.55 % 5.42 % -8.14 %
Seq. Capital Expenditures Change (Q3 TTM) -26.42 % -4.42 % 0.77 % 18.42 %
Capital Expenditures 5 Year Avg. Change -31.57 % 11.38 % 9.25 % 8.65 %

Note
To view Detail Information & Trends click on Individual Category.
To see Industry, Sector or S&P 500 Performance, click on each Category respectivly, on the top of the Table.

For explanation of terms visit: Glossary
 







Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com